药品注册申请号:217879
申请类型:ANDA (仿制药申请)
申请人:AUROBINDO PHARMA
申请人全名:AUROBINDO PHARMA LTD
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.3MG No No AB 2023/10/26 2023/10/26 Prescription
002 NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.4MG No No AB 2023/10/26 Prescription
003 NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.6MG No No AB 2023/10/26 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2023/10/26 ORIG-1(原始申请) Approval STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:NITROGLYCERIN 剂型/给药途径:TABLET;SUBLINGUAL 规格:0.3MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021134 001 NDA NITROSTAT NITROGLYCERIN TABLET;SUBLINGUAL 0.3MG Prescription Yes No AB 2000/05/01 VIATRIS
208191 001 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.3MG Prescription No No AB 2016/08/26 DR REDDYS
206391 001 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.3MG Prescription No No AB 2017/09/19 GLENMARK SPECLT
211604 001 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.3MG Prescription No No AB 2019/04/30 NATCO
209779 001 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.3MG Prescription No No AB 2021/05/03 RUBICON
210153 001 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.3MG Discontinued No No AB 2022/03/08 ZYDUS PHARMS
217879 001 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.3MG Prescription No No AB 2023/10/26 AUROBINDO PHARMA
217970 001 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.3MG Prescription No No AB 2023/12/05 MANKIND PHARMA
218583 001 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.3MG Prescription No No AB 2024/10/15 VIWIT PHARM
活性成分:NITROGLYCERIN 剂型/给药途径:TABLET;SUBLINGUAL 规格:0.4MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021134 002 NDA NITROSTAT NITROGLYCERIN TABLET;SUBLINGUAL 0.4MG Prescription Yes No AB 2000/05/01 VIATRIS
208191 002 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.4MG Prescription No No AB 2016/08/26 DR REDDYS
206391 002 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.4MG Prescription No No AB 2017/09/19 GLENMARK SPECLT
211604 002 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.4MG Prescription No No AB 2019/04/30 NATCO
209779 002 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.4MG Prescription No No AB 2021/05/03 RUBICON
210153 002 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.4MG Discontinued No No AB 2022/03/08 ZYDUS PHARMS
217879 002 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.4MG Prescription No No AB 2023/10/26 AUROBINDO PHARMA
217970 002 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.4MG Prescription No No AB 2023/12/05 MANKIND PHARMA
218583 002 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.4MG Prescription No No AB 2024/10/15 VIWIT PHARM
活性成分:NITROGLYCERIN 剂型/给药途径:TABLET;SUBLINGUAL 规格:0.6MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
021134 003 NDA NITROSTAT NITROGLYCERIN TABLET;SUBLINGUAL 0.6MG Prescription Yes Yes AB 2000/05/01 VIATRIS
208191 003 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.6MG Prescription No No AB 2016/08/26 DR REDDYS
206391 003 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.6MG Prescription No No AB 2017/09/19 GLENMARK SPECLT
211604 003 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.6MG Prescription No No AB 2019/04/30 NATCO
209779 003 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.6MG Prescription No No AB 2021/05/03 RUBICON
210153 003 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.6MG Discontinued No No AB 2022/03/08 ZYDUS PHARMS
217879 003 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.6MG Prescription No No AB 2023/10/26 AUROBINDO PHARMA
217970 003 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.6MG Prescription No No AB 2023/12/05 MANKIND PHARMA
218583 003 ANDA NITROGLYCERIN NITROGLYCERIN TABLET;SUBLINGUAL 0.6MG Prescription No No AB 2024/10/15 VIWIT PHARM
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database